Impella CP Archives | Be Korea-savvy
Abiomed Announces First Patient Enrolled in STEMI DTU Feasibility Study

Abiomed Announces First Patient Enrolled in STEMI DTU Feasibility Study

DANVERS, Mass., May 4 (Korea Bizwire) — Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support technologies, announced today the enrollment of the first patient in the Food and Drug Administration (FDA) approved prospective feasibility study, STEMI Door to Unloading (DTU) with Impella CP® system in acute myocardial infarction. This trial will focus on [...]